Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Final Four Stocks: Celgene vs. Johnson & Johnson
Motley Fool
Sunday, April 7, 2013 - 10:57am
tags:
Celgene, JNJ
3 Things Buffett Likes About Health Care
Motley Fool
Sunday, April 7, 2013 - 10:55am
tags:
Warren Buffett
This Week in Biotech
Motley Fool
Sunday, April 7, 2013 - 10:55am
tags:
JNJ, Optimer, Biogen, Merck, Cubist Pharmaceuticals, AstraZeneca, Rigel Pharmaceuticals, AbbVie, Pfizer
3 Biotechs With Recent Intensive Insider Buying
Seeking Alpha
Sunday, April 7, 2013 - 10:52am
tags:
Tetraphase Pharmaceuticals, Enanta, Inovio
How to Play the Immediate Uncertainty of this Promising Biotech Stock
Motley Fool
Sunday, April 7, 2013 - 10:45am
tags:
Sarepta Therapeutics
Amgen: Long-Term Buy After A Pull Back
Seeking Alpha
Sunday, April 7, 2013 - 10:44am
tags:
Amgen
This Biotech Stock Looks Like a Good Investment
Motley Fool
Sunday, April 7, 2013 - 10:44am
tags:
Immunogen
Why Acadia Pharmaceuticals Remains A Strong Buy
Seeking Alpha
Sunday, April 7, 2013 - 10:43am
tags:
Acadia
Should You Bet on These Hot Healthcare Stocks?
Motley Fool
Sunday, April 7, 2013 - 10:42am
tags:
Gilead Sciences, Cadence Pharmaceuticals, United Health
How Doctors Actually Diagnose Obesity
Motley Fool
Sunday, April 7, 2013 - 10:41am
tags:
obesity, weight loss, Vivus, Arena Pharmaceuticals, Orexigen, Belviq, Qsymia, Contrave
Can Teva's Short-Term Pressure Be Justified?
Seeking Alpha
Saturday, April 6, 2013 - 11:16am
tags:
Teva
Cadila recalls anti-depressant generic batches from US
Business Standard, India
Saturday, April 6, 2013 - 11:14am
tags:
Cadila, Venlafaxine Hydrochloride, recalls
Aquinox Pharmaceuticals Nabs $18M Series C Funding
PE Hub
Saturday, April 6, 2013 - 11:13am
tags:
Aquinox Pharmaceuticals
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, April 6, 2013 - 11:11am
tags:
JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
AZ arthritis drug may ease symptoms, but not progression
Delaware Online
Saturday, April 6, 2013 - 11:10am
tags:
AstraZeneca, rheumatoid arthritis, arthritis, fostamatinib
KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Phase IIIb Study of ATX-101 at the 11th Anti-Aging Medicine World Congress (AMWC)
Yahoo/BusinessWire
Saturday, April 6, 2013 - 11:07am
tags:
ATX-101, Kythera Biopharmaceuticals
AstraZeneca's Arthritis Drug Succeeds in Phase 3 Trial
Motley Fool
Saturday, April 6, 2013 - 11:06am
tags:
AstraZeneca, fostamatinib, rheumatoid arthritis, arthritis
The Wild Story Behind A Promising Experimental Cancer Drug
Forbes
Saturday, April 6, 2013 - 11:04am
tags:
ibrutinib, Pharmacyclics, chronic lymphocytic leukemia, mantle cell lymphoma, JNJ
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Impax Laboratories, Inc.
Yahoo/BusinessWire
Saturday, April 6, 2013 - 11:03am
tags:
Impax Laboratories
Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
Yahoo/PR Newswire
Saturday, April 6, 2013 - 11:02am
tags:
Anthera

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.